Register
Login:
Share:
Email Facebook Twitter

Cornhill Capital sees strong investor enthusiasm in London IPOs Watch here

Cornhill Capital sees strong investor enthusiasm in London IPOs


Astrazeneca Share Price (AZN)



Share Price Information for Astrazeneca (AZN)


Share Price: 4,637.50Bid: 4,636.00Ask: 4,637.50Change: 0.00 (0.00%)No Movement on Astrazeneca
Spread: 1.50Spread as %: 0.03%Open: 4,709.50High: 4,709.50Low: 4,614.00Yesterday’s Close: 4,637.50

Astrazeneca Plc Ord Shs $0.25

Astrazeneca is listed in the FTSE 100, FTSE All-Share, FTSE 350, FTSE 350 High Yield
Astrazeneca is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
4637.50

Share Price SpacerBid
4636.00

Share Price SpacerAsk
4637.50

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
1,918,186

Share Price SpacerOpen
4,709.50

Share Price SpacerHigh
4,709.50

Share Price SpacerLow
4,614.00

Share Price SpacerClose
4,637.50

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 1,265.23m £58,674.99m 500

52 Week High 5,505.00 52 Week High Date 5-AUG-2016
52 Week Low 3,680.00 52 Week Low Date 24-JUN-2016

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
9,533 540,599 1,376,402 22.600 205.20 199.70 4.31


London South East Users info for Astrazeneca




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

28-Apr-17
17:03:39
4,636.665
16,504
Sell* 
4,636.00
4,637.50
765.24k
Trade Type:
Ordinary
Deletion
Bargain conditions apply

28-Apr-17
17:03:40
4,637.175
18,031
Buy* 
4,636.00
4,637.50
836.13k
Trade Type:
Ordinary
Deletion
Bargain conditions apply

28-Apr-17
17:02:48
4,637.2558
3,000
Buy* 
4,636.00
4,637.50
139.12k
Trade Type:
Ordinary
Deletion
Bargain conditions apply




View more Astrazeneca trades >>

Directors Deals for Astrazeneca (AZN)
Trade DateActionNotifierPriceCurrencyAmountHolding
28-Mar-17Transfer From
Trade Notifier Information for AstraZeneca
Marc Dunoyer held the position of CFO & Executive Director at AstraZeneca at the time of this trade.
 Marc Dunoyer
01,419364343
28-Mar-17Transfer From
Trade Notifier Information for AstraZeneca
Pascal Soriot held the position of CEO and Executive director at AstraZeneca at the time of this trade.
 Pascal Soriot
0101,584556521
28-Mar-17Transfer From
Trade Notifier Information for AstraZeneca
Marc Dunoyer held the position of CFO & Executive Director at AstraZeneca at the time of this trade.
 Marc Dunoyer
025,478364343
View more Astrazeneca directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
21 Apr '17MaruRE: RE:RE: Thoughts4,575.00No Opinion
This is the kind of news that excites me :) I'll hold until then. It's certainly a good stock, no doubt about it, it's just I'm particularly bullish for the prospects of the pound and although investing is all about long term holding, If you could avoid 2008, you would have right :P

Not that this is anything similar, but yeah.

Anyway, April 27th it is, cheers mate.
21 Apr '17GraylingRE:RE: Thoughts4,532.00Hold
Q1 results are also due next Thursday 27th April. That may set a direction one way or the other :-)
21 Apr '17GraylingRE:Thoughts4,524.50Hold
Same as ever. Hold, hold, hold, for the income and if you feel confident long term, then buy on the dips. It has fluctuated between £40-£50 ever since the failed TO by Pfizer. This is not a share to fret over each time it drops.
21 Apr '17MaruThoughts4,554.50No Opinion
Thoughts on this now? The strengthening pound seems to be lowering the price considerably! Where is the bottom, it keeps closing down every day. I was looking at 10% profit, now I'm up by 2.8% sell in profit, or wait for it to reverse?
14 Apr '17oldabutnowisaExcitement soon!4,743.00Weak Buy
This is a quality pharma with a beefy divi and lots of RNS coming soon. It only needs one new drug turning from research into reality for this sp to motor. There is also still the outside chance of another bid using a stronger currency than Sterling. You have to be pretty churlish to sell AZN now!
12 Apr '17VicmyRE: 25.5% upside4,737.00Strong Buy
If a stock is recommended to be "overweight", the analyst opines that the stock is better value for money than others.

GLA!!

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Astrazeneca (AZN) >>

Please login or register to post a message on Share Chat.





Astrazeneca Plc Ord Shs $0.25 home pageWebsite: Astrazeneca Plc Ord Shs $0.25
Website Description: AstraZeneca International - pharmaceutical company - prescription drugs - medicine manufacturers



Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.